Anti-ERK1 antibody [Y72] (Ab32537)
ERK1, PRKM3, MAPK3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, Microtubule-associated protein 2 kinase, p44-ERK1, ERK-1, p44-MAPK
详细信息
特异性
This antibody recognises ERK1.The antibody does not cross-react with other MAP kinases.
背景信息
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
文献引用 (86)
Albiflorin-Mediated MAP2K1 Targeting and HIF-1 Signaling Inhibition Contribute to the Therapeutic Efficacy in Hyperuricemia-Associated Cognitive Impairment.
白花苷介导的 MAP2K1 靶向和 HIF-1 信号抑制有助于治疗高尿酸血症相关的认知障碍。
Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling.
激酶组筛选发现整合应激反应激酶 EIF2AK1/HRI 是 PINK1 线粒体自噬信号的负调控因子
ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression.
ERK2 介导的 ZEB1 在 S322 位点的磷酸化增强了 PD-L1 的表达和 EMT,从而导致胰腺癌的进展
ESM1 promote proliferation, invasion and angiogenesis via Akt/mTOR and Ras pathway in kidney renal clear cell carcinoma
ESM1通过Akt / mTOR和Ras通路促进肾透明细胞癌的增殖,侵袭和血管生成
Silencing PPAP2C inhibits lung adenocarcinoma migration and invasion via the ERK/JNK pathway
沉默 PPAP2C 通过 ERK/JNK 通路抑制肺腺癌迁移和侵袭
Circ_0060927 regulates miR-331-3p/ERK/MAPK pathway reaction in non-small cell lung cancer through METTL14-driven methylation.
Circ_0060927 通过 METTL14 驱动的甲基化调节非小细胞肺癌中的 miR-331-3p/ERK/MAPK 通路反应。
Deletion of the plexin-D1 ectodomain leads to anoikis by suppressing integrin inside-out signaling
plexin-D1胞外结构域的缺失通过抑制整合素由内而外的信号传导导致失巢凋亡
miR-155 promotes m6A modification of SOX2 mRNA through targeted regulation of HIF-1α and delays wound healing in diabetic foot ulcer in vitro models
miR-155 通过靶向调控 HIF-1α 促进 SOX2 mRNA 的 m6A 修饰,延缓糖尿病足溃疡体外模型中的伤口愈合
TIMP1 promotes microglia M2 polarization through MAPK pathway to ameliorate early brain injury after ischemia.
TIMP1 通过 MAPK 通路促进小胶质细胞 M2 极化,从而减轻缺血后的早期脑损伤
Jujuboside B inhibits proliferation and induces apoptosis and ferroptosis in colorectal cancer cells with potential involvement of the MAPK signaling pathway
酸枣皂苷 B 抑制结肠直肠癌细胞增殖并诱导细胞凋亡和铁死亡,可能与 MAPK 信号通路有关
- 1
- 2
- 3
- 4
- 5
- 6
- 9